Chronic heart failure and the substrate for atrial fibrillation

Aims We sought to define the underlying mechanisms for atrial fibrillation (AF) during chronic heart failure (HF). Methods and results Preliminary studies showed that 4 months of HF resulted in irreversible systolic dysfunction (n = 9) and a substrate for sustained inducible AF (>3 months, n = 3). We used a chronic (4-month) canine model of tachypacing-induced HF (n = 10) to assess atrial electrophysiological remodelling, relative to controls (n = 5). Left ventricular fractional shortening was reduced from 37.2 +/- 0.83 to 13.44 +/- 2.63% (P < 0.05). Left atrial. (LA) contractility (fractional area change) was reduced from 34.9 +/- 7.9 to 27.9 +/- 4.23% (P < 0.05). Action potential durations (APDs) at 50 and 90% repolarization were shortened by similar to 60 and 40%, respectively, during HF (P < 0.05). HF-induced atrial remodelling included increased fibrosis, increased/(to), and decreased I-K1, I-Kun, and I-KS (P < 0.05). HF induced increases in LA Kv channel interacting protein 2 (P < 0.05), no change in Kv4.3, Kv1.5, or Kir2.3, and reduced Kir2.1 (P < 0.05). When /(ca-L) was elicited by action potential (AP) clamp, HF Alps reduced the integral of I-Ca in control myocytes, with a larger reduction in HF myocytes (P < 0.05). I-CaL measured with standard voltage clamp was unchanged by HE Incubation of myocytes with N-acetylcysteine (a glutathione precursor) attenuated HF-induced electrophysiological alterations. LA angiotensin-1 receptor expression was increased in HE Conclusion Chronic HF causes alterations in ion channel expression and ion currents, resulting in attenuation of the APD and atrial. contractility and a substrate for persistent AF